Anti-biofilm peptides are a subset of antimicrobial peptides and represent promising broad-
spectrum agents for the treatment of bacterial biofilms, though some display host toxicity in …

Biofilms are widely involved in human lives, such as in medical infection, environmental
remediation, and industrial processes. However, the control of the biofilm has still been a …

Host defense (antimicrobial) peptides (HDPs) are produced by virtually all organisms and
have an important role in protection against microbial infections. Some naturally occurring …

Highly antibiotic resistant, microbial communities, referred to as biofilms, cause various life-
threatening infections in humans. At least two-thirds of all clinical infections are biofilm …

Biofilms are multicellular communities of bacteria that can adhere to virtually any surface.
Bacterial biofilms are clinically relevant, as they are responsible for up to two-thirds of …

Biofilms are resistant to antibiotics and are a major source of persistent and recurring
infections by clinically important pathogens. Drugs used for biofilm-associated infections are …

Biofilms cause up to 80% of infections and are difficult to treat due to their substantial
multidrug resistance compared to their planktonic counterparts. Based on the observation …

The emergence of multidrug-resistant bacterial pathogens is a growing threat to global
public health. Here, we report the development and characterization of a panel of nine …

The problem of drug resistance is very worrying and ever increasing. Resistance is due not
only to the reckless use of antibiotics but also to the fact that pathogens are able to adapt to …

The treatment of bacterial diseases is facing twin threats, with increasing bacterial antibiotic
resistance and relatively few novel compounds or strategies under development or entering …